Registro:

Referencias:

• Rosmalen, J.G., Islet abnormalities in the pathogenesis of autoimmune diabetes (2002) Trends Endocrinol. Metab., 13, pp. 209-214
• Winer, S., Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive (2003) Nat. Med., 9, pp. 198-205
• Hamilton-Williams, E.E., Beta cell MHC class I is a late requirement for diabetes (2003) Proc. Natl. Acad. U. S. A., 100, pp. 6688-6693
• Bonner-Weir, S., Orci, L., New perspectives on the microvasculature of the islets of Langerhans in the rat (1982) Diabetes, 31, pp. 883-889
• Solimena, M., GAD, diabetes, and Stiff-Man syndrome: Some progress and more questions (1994) J. Endocrinol. Invest., 17, pp. 509-520
• Atouf, F., Expression of neuronal traits in pancreatic β cells. Implication of neuron-restrictive silencing factor/repressor element silencing transcription factor, a neuron-restrictive silencer (1997) J. Biol. Chem., 272, pp. 1929-1934
• Edlund, H., Pancreatic organogenesis - developmental mechanisms and implications for therapy (2002) Nat. Rev. Genet., 3, pp. 524-532
• Winer, S., Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; Nonimmunized nonobese diabetic mice can develop autoimmune encephalitis (2001) J. Immunol., 166, pp. 2831-2841
• Winer, S., T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice (2001) J. Immunol., 166, pp. 4751-4756
• Salomon, B., Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice (2001) J. Exp. Med., 194, pp. 677-684
• Ichikawa, M., IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice (1999) Cell. Immunol., 191, pp. 97-104
• Slavin, A., Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein (1998) Autoimmunity, 28, pp. 109-120
• Saravia, F.E., Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: The nonobese diabetic (NOD) and streptozotocin-treated mice (2002) Brain Res., 957, pp. 345-353
• Aloisi, F., Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes (2000) Immunol. Today, 21, pp. 141-147
• Fischer, H.G., Reichmann, G., Brain dendritic cells and macrophages/microglia in central nervous system inflammation (2001) J. Immunol., 166, pp. 2717-2726
• Durant, S., Proapoptosis and antiapoptosis-related molecules during postnatal pancreas development in control and nonobese diabetic mice: Relationship with innervation (2003) Lab. Invest., 83, pp. 227-239
• Honjin, H., The innervation of the pancreas of the mouse, with special reference to the structure of the peripheral extension of the vegetative nervous system (1956) J. Comp. Neurology, 104, pp. 331-371
• Sorenson, R.L., Structural and functional considerations of GABA in islets of Langerhans. Beta-cells and nerves (1991) Diabetes, 40, pp. 1365-1374
• Saravia-Fernandez, F., Localization of gamma-aminobutyric acid and glutamic acid decarboxylase in the pancreas of the nonobese diabetic mouse (1996) Endocrinology, 137, pp. 3497-3506
• Boitard, C., Peripherin: An islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 172-176
• Kaufman, D.L., Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes (1993) Nature, 366, pp. 69-72
• Tisch, R., Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice (1993) Nature, 366, pp. 72-75
• Mei, Q., Early, selective, and marked loss of sympathetic nerves from the islets of BioBreeder diabetic rats (2002) Diabetes, 51, pp. 2997-3002
• Saikumar, P., Apoptosis: Definition, mechanisms, and relevance to disease (1999) Am. J. Med., 107, pp. 489-506
• Charré, S., Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic mice during the early neonatal period (2002) Histol. Histopathol., 17, pp. 393-401
• Chernousov, M.A., Carey, D.J., Schwann cell extracellular matrix molecules and their receptors (2000) Histol. Histopathol., 15, pp. 593-601
• Lilje, O., Armati, P.J., The distribution and abundance of MHC and ICAM-1 on Schwann cells in vitro (1997) J. Neuroimmunol., 77, pp. 75-84
• Kwa, M.S., Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies (2003) Brain, 126, pp. 361-375
• Kaufman, D.L., Murder mysteries in type 1 diabetes (2003) Nat. Med., 9, pp. 161-162
• O'Brien, B.A., Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced (2002) Diabetes, 51, pp. 2481-2488
• Fadok, V.A., Phagocyte receptors for apoptotic cells: Recognition, uptake, and consequences (2001) J. Clin. Invest., 108, pp. 957-962
• Cha, S., Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy (2001) Exp. Clin. Immunogenet., 18, pp. 143-160
• Esch, T.R., Taubman, M.A., Autoantibodies in salivary hypofunction in the NOD mouse (1998) Ann. N. Y. Acad. Sci., 842, pp. 221-228
• Jansen, A., An immunohistochemical study on organized lymphoid cell infiltrates in fetal and neonatal pancreases. A comparison with similar infiltrates found in the pancreas of a diabetic infant (1993) Autoimmunity, 15, pp. 31-38
• Delovitch, T.L., Singh, B., The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD (1997) Immunity, 7, pp. 727-738
• Hampe, C.S., Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes (1999) Horm. Metab. Res., 31, pp. 553-557
• Undlien, D.E., Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene (1995) Diabetes, 44, pp. 620-625
• Todd, J.A., Wicker, L.S., Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models (2001) Immunity, 15, pp. 387-395
• Naya, F.J., Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice (1997) Genes Dev., 11, pp. 2323-2334
• Lieberman, S.M., Identification of the {beta} cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes (2003) Proc. Natl. Acad. Sci. U. S. A., 100, pp. 8384-8388
• Martin, C.C., Upstream stimulatory factor (USF) and neurogenic differentiation/β- cell E box transactivator 2 (NeuroD/BETA2) contribute to islet-specific glucose-6-phosphatase catalytic-subunit-related protein (IGRP) gene expression (2003) Biochem. J., 371, pp. 675-686
• Pleau, J.M., Pancreatic hormones and glutamic acid decarboxylase (GAD) expression in the mouse thymus: A real-time PCR study (2001) Biochem. Biophys. Res. Com., 283, pp. 843-848

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------